# OneVentures

OneVentures is a Venture Capital based in Sydney, Australia.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Sydney, Australia
- **Region:** Oceania
- **Address:** Sydney, Australia
- **Founded:** 2007
- **Assets under management:** $1B (Altss estimate)
- **Website:** one-ventures.com.au
- **LinkedIn:** https://www.linkedin.com/company/oneventures-vc

## Regulatory record

- **Reports private funds:** No

## About

We are one of Australia’s leading venture capital firms, with $900M million in funds under management. But we do more than invest. We work with companies to take them to that all important next stage, by actively shaping their future.

## Sectors

- Enterprise Software
- FinTech
- Digital Health
- AI/ML
- SpaceTech
- Healthcare Services
- Private Credit

## People

- Dr Michelle Deaker — Founding Partner and Managing Partner
- Dr Paul Kelly — Founding Partner, Healthcare and Biotechnology

## Questions

### Who runs investment decisions at OneVentures?

Founding Partner and Managing Partner Dr Michelle Deaker chairs the investment committees for the growth equity and credit practices. Founding Partner Dr Paul Kelly chairs the healthcare-focused committees. Each pillar — Growth Equity, Growth Credit, and Healthcare — operates its own dedicated investment committee advised by venture partners with domain expertise.

### How does OneVentures source proprietary deal flow?

The firm draws on a physician-scientist network in healthcare and an operator network in technology built over 25 years. Michelle Deaker's history as an angel investor and entrepreneur-in-residence, combined with Paul Kelly's academic and clinical relationships, gives the healthcare team access to university and research-hospital spinouts before broad auction processes begin.

### Does OneVentures participate in fund commitments or only direct deals?

The firm makes direct equity investments, provides venture debt, and at times co-invests alongside other institutional investors. Its credit practice, launched in 2019, gives portfolio companies an alternative to equity rounds, and the firm has not publicly positioned itself as a fund-of-funds investor.

### What investment stages does OneVentures typically target?

Growth Equity targets scale-up technology businesses, often post-revenue, that need capital for international expansion or restructuring. Healthcare spans early to mid-stage biotech and medical devices. Growth Credit lends to revenue-generating technology companies that want to avoid equity dilution, placing the firm across expansion and late-stage venture in the same portfolio.

### How is OneVentures related to the Australian Government's Biomedical Translation Fund?

OneVentures was a recipient of a mandate under the Biomedical Translation Fund, a federal program that co-invests in commercial-stage life sciences companies. This public-private structure gave the firm dedicated follow-on capital for healthcare portfolio companies such as Vaxxas and BiVACOR and shaped the hybrid healthcare vehicle.

## Related profiles

- [ONEVC](https://altss.com/profile/onevc)
- [One Way Ventures](https://altss.com/profile/one-way-ventures)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/oneventures

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology